Cite
HARVARD Citation
Popmihajlov, Z. et al. (2022). CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial. BMJ open respiratory research. 9 (1), p. . [Online].